Complexa
Closed
- Headquarters
- Berwyn
- Employees
- 11–50
- Founded
- 2012
- Business Model
- B2B
- Website
- complexarx.com
- Last Round
- Series CJul 2017
About
Complexa Inc. is a clinical-stage biopharmaceutical company based in Berwyn, Pennsylvania, developing nitrated fatty acids (NFAs) for the treatment of debilitating fibrotic and inflammatory orphan diseases. Its lead compound CXA-10 is in Phase 2 development for focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH). Investors include NEA, Pfizer Venture Investments, Andera Partners, HBM Healthcare Investments, and JAFCO.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free AccountInvestors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free Account